Interleukin-2 mutation gene and its preparation
A technology for mutant gene and interleukin, which is applied in the field of interleukin-2 mutant gene and its preparation, and can solve the problems of high synthesis cost, lack of emphasis, and many mutation sites.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0029] An interleukin-2 mutant gene, having the sequence shown in SEQ ID NO: 1:
[0030] (1) Information of SEQ ID NO.1 (see sequence listing)
[0031] (a) Sequence features:
[0032] * Length: 399 bp
[0033] *Type: nucleic acid
[0034] * Chain type: double chain
[0035] *Topology: Linear
[0036] (b) Molecular type: cDNA
[0037] (c) Assumption: No
[0038] (d) Antisense: no
[0039] (e) Original source: interleukin-2 (human interleukin 2)
[0040] Material:
[0041] Bacterial strains and E.coli DH5α, JM109 (DE3) are commercially available;
[0042] Plasmid: a plasmid containing the IL-2 gene obtained by the mutation, a PTE-30a-(+) expression vector, and a 7ZTS vector (see Chinese patent application 02109681.3) constructed in this example (commercially available 7Z can also be used instead);
[0043] Molecular biology reagents: Taq DNA polymerase, Pfu DNA polymerase, dNTP, hind III, Nde I, T4 DNA Ligase are all products of Promega Company in the United States, ge...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com